
Amprius Technologies, Inc. (NYSE:AMPX – Free Report) – Equities researchers at Northland Securities lifted their Q1 2026 earnings per share (EPS) estimates for shares of Amprius Technologies in a research report issued to clients and investors on Monday, March 9th. Northland Securities analyst E. Jackson now forecasts that the company will post earnings per share of ($0.03) for the quarter, up from their prior forecast of ($0.04). The consensus estimate for Amprius Technologies’ current full-year earnings is ($0.45) per share. Northland Securities also issued estimates for Amprius Technologies’ Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.02) EPS and FY2026 earnings at ($0.08) EPS.
Amprius Technologies (NYSE:AMPX – Get Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.03. The firm had revenue of $25.23 million during the quarter, compared to analysts’ expectations of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS.
Read Our Latest Research Report on Amprius Technologies
Amprius Technologies Price Performance
AMPX stock opened at $17.91 on Wednesday. The business has a fifty day moving average price of $11.27 and a 200 day moving average price of $10.90. Amprius Technologies has a fifty-two week low of $1.70 and a fifty-two week high of $18.95. The stock has a market capitalization of $2.34 billion, a price-to-earnings ratio of -52.66 and a beta of 3.04.
Insider Activity at Amprius Technologies
In other news, Director Kang Sun sold 61,251 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $10.16, for a total transaction of $622,310.16. Following the transaction, the director owned 1,342,400 shares of the company’s stock, valued at approximately $13,638,784. This represents a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CTO Constantin Ionel Stefan sold 25,366 shares of the company’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $10.16, for a total transaction of $257,718.56. Following the transaction, the chief technology officer owned 723,330 shares in the company, valued at approximately $7,349,032.80. This trade represents a 3.39% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 2,392,269 shares of company stock worth $26,384,359 over the last three months. 12.80% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Amprius Technologies
Several hedge funds and other institutional investors have recently bought and sold shares of AMPX. Bank of America Corp DE increased its holdings in shares of Amprius Technologies by 31.1% during the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after buying an additional 3,055 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of Amprius Technologies by 86.7% in the 1st quarter. AQR Capital Management LLC now owns 77,764 shares of the company’s stock valued at $208,000 after purchasing an additional 36,116 shares during the last quarter. Millennium Management LLC boosted its position in shares of Amprius Technologies by 94.5% during the first quarter. Millennium Management LLC now owns 1,396,013 shares of the company’s stock worth $3,741,000 after buying an additional 678,442 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Amprius Technologies by 128.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 244,646 shares of the company’s stock valued at $656,000 after buying an additional 137,640 shares during the period. Finally, Rhumbline Advisers boosted its holdings in Amprius Technologies by 61.1% during the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after acquiring an additional 5,951 shares during the period. 5.04% of the stock is currently owned by institutional investors and hedge funds.
More Amprius Technologies News
Here are the key news stories impacting Amprius Technologies this week:
- Positive Sentiment: Northland Securities materially raised near-term and long-term earnings assumptions (Q1–Q3 FY26 upgrades and FY26 improved to -$0.08 EPS from -$0.14; FY27 now modeled positive). The firm’s repeated estimate lifts signal improving analyst confidence in Amprius’ ramp and margins. Northland estimates report
- Positive Sentiment: B. Riley raised its price target to $22 and kept a Buy rating, citing company progress after the latest results — a concrete, bullish analyst endorsement that can attract buy-side demand. B. Riley coverage
- Positive Sentiment: Needham reaffirmed its Buy rating with a $20 target, adding more sell‑side support and reinforcing upside expectations. Needham note
- Positive Sentiment: MarketBeat and other outlets flag record trading volume, technical momentum and early institutional accumulation — volume-driven conviction that often validates and amplifies price moves. MarketBeat volume/technical piece
- Positive Sentiment: Investor-facing coverage upgrades (including IBD rating improvement) and positive media pieces increase visibility and may draw new retail and institutional interest. IBD upgrade
- Neutral Sentiment: Recent Q4 results beat revenue and EPS expectations, which triggered the coverage lift; upcoming quarterly reports and execution on contract manufacturing/production ramp remain primary near-term catalysts. Earnings summary
- Negative Sentiment: Amprius is still unprofitable (negative net margin and ROE) with a consensus FY EPS around -$0.45; high beta (~3.0) implies elevated volatility and risk if execution or demand disappoints. Company fundamentals
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Recommended Stories
- Five stocks we like better than Amprius Technologies
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
